Insider · CIK 0002062181
Peter Fong
Files at RCKT (ROCKET PHARMACEUTICALS, INC.). First filing -, latest -.
Peter Fong files SEC Form 4 as director at RCKT (ROCKET PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Peter Fong has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Common Stock | +23,333 | $0.00 | $0 | 23,333 | Oct 3, 2025 |
| Sep 24, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 53,333 | Oct 3, 2025 |
Questions about Peter Fong
Answered from the filings on this page, as of the latest one.
Is Peter Fong buying or selling?
Peter Fong has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Peter Fong's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter Fong has 0.
Where does Peter Fong file Form 4?
Peter Fong has filed Form 4 at RCKT (ROCKET PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.